PKC‐δ enhances the HIF‐1α transcriptional activity by increasing the nuclear translocation, and VitK2 suppresses the HIF‐1α activation through the inhibition of PKC in HCC cells. Here, PRKCD is linked to hepatocellular carcinoma.